Ratnakar Securities

Mobile Trading
COMPANY
more from company profile
HomeMarket Info Company Profile Smart Quotes

Smart Quotes

AMRUTANJAN HEALTH CARE LTD.

NSE : AMRUTANJANBSE : 590006ISIN CODE : INE098F01031Industry : Pharmaceuticals & DrugsHouse : Amrutanjan
BSE671.7016.35 (+2.49 %)
PREV CLOSE ( ) 655.35
OPEN PRICE ( ) 652.55
BID PRICE (QTY) 667.45 (22)
OFFER PRICE (QTY) 672.60 (46)
VOLUME 1565
TODAY'S LOW / HIGH ( )650.05 678.60
52 WK LOW / HIGH ( )548.05 829
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 09-09 1936
Management Info
S Sambhu Prasad - Chairman S Sambhu Prasad - Managing Director
Registered Office

Address New 103 (Old 42-45),Luz Church Road,Mylapore,
Chennai,
Tamil Nadu-600004

Phone 044-24994164 / 24994146 / 24994465 / 24994366 / 24669000

Email customercare@amrutanjan.com

Website www.amrutanjan.com

Registrars Details
Cameo Corporate Services Ltd
Subramanian Buildings No 1 ,Club House Road,,Chennai
 Listing : BSE, NSE
NEWS
04Nov Amrutanjan Health Care informs about b
Pursuant to Regulation 29(1) of SEBI (Listing Obligations & Disclosu..
18Oct Amrutanjan Health Care informs about u
Pursuant to the Regulation 30 read with Clause 20 of Para A of Part A of..
07Jul Amrutanjan Health Care informs about R
Amrutanjan Health Care has informed that it enclosed the certificate iss..
07Apr Amrutanjan Health Care informs about c
Pursuant to Regulation 74 (5) of the SEBI (Depository Participants) Regu..
17Jul Amrutanjan Health Care informs about l
Amrutanjan Health Care has informed that the Company has received a requ..
MORE
Financials
in Millions
QTR Sep 25 ANNUAL 25
Net Profit139.6508.36
Gross Profit 192.13 691.35
Operating Profit 208.21758.8
Net Sales 11774518.16
MORE
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Ajanta Pharma (BSE)
up  2679.05 (1.53%)
M.Cap ( in Cr)33334.70
Mercury Laboratories (BSE)
up  896.00 (1.96%)
M.Cap ( in Cr)105.46
Albert David (BSE)
up  784.40 (2.23%)
M.Cap ( in Cr)450.10
Trident Lifeline (BSE)
up  320.00 (5.54%)
M.Cap ( in Cr)374.33
Venus Remedies (BSE)
up  760.30 (2.03%)
M.Cap ( in Cr)1039.95
MORE
Shareholding Pattern
MUTUAL FUNDS/UTI 7.55%
PROMOTERS 46.52%
NON-INSTITUTION 38.2%
FI/BANKS/INSURANCE 0.09%
GOVERNMENT 0%
FII 0%
MORE
Mf Holdings
MORE
FAQs
079-49005200 / 01 / 02
info@ratnakarsecurities.com
Download Mobile App

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER
products
about us
usefull links
news room

Ratnakar Securities Pvt. Ltd. : SEBI Registration No. of NSE, BSE : INZ000191735 | SEBI Registration No. of NSDL : IN-DP-NSDL-66-88
Ratnakar Commodities Pvt. Ltd : SEBI Registration No. of MCX : INZ000024138
Investor Grievance ID : investorgrievance@ratnakarsecurities.com
Online Dispute Resolution Portal - SMART ODR
To File A Complaint on SCORES Click Here
For Nomination, Please Click Here
To Close Account, Please Click Here
© 2018 Ratnakar Securities Pvt. Ltd. All rights reserved.
Designed, Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
CLOSE X

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal (link:https://scores.gov.in)
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.